Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00994838 · ClinicalTrials.gov registry record · Phase 2
Reduced Calorie Diet Intervention in Kidney Transplant Recipients
A Phase 2 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
NCT00994838 is a Phase 2 study that has completed, run by Vanderbilt University. The registered enrollment target is 27 participants.
The verdict
NCT00994838, a Phase 2 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the effect of a reduced calorie diet intervention in new kidney transplant recipients on the outcomes weight gain, oxidative stress, and insulin resistance.
Interventions
- OTHER reduced calorie diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2009-10 |
| Est. Completion | 2014-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00994838
The ClinicalTrials.gov registry entry for NCT00994838 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which reduced calorie diet is the first listed.
NCT00994838 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00994838 about?
NCT00994838 is a clinical study titled "Reduced Calorie Diet Intervention in Kidney Transplant Recipients". The purpose of this study is to measure the effect of a reduced calorie diet intervention in new kidney transplant recipients on the outcomes weight gain, oxidative stress, and insulin resistance.
What is the current status of trial NCT00994838?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2009-10. Estimated completion is 2014-01.
What interventions are being tested in trial NCT00994838?
The interventions under investigation include: reduced calorie diet (OTHER).
Who is sponsoring clinical trial NCT00994838?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.